DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Acer Therapeutics (NASDAQ: ACER) and Encourages Acer Investors to Contact the Firm
Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Acer Therapeutics, Inc. (NASDAQ: ACER) securities between September 25, 2017 and June 24, 2019 (the "Class Period"). Investors have until August 30, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
The complaint, filed on ...